Dr Reddy's Laboratories Current Ratio 2006-2018 | RDY

Current and historical current ratio for Dr Reddy's Laboratories (RDY) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Dr Reddy's Laboratories current ratio for the three months ending December 31, 2018 was 1.81.
Dr Reddy's Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $1.62B $0.90B 1.81
2018-09-30 $1.59B $0.98B 1.62
2018-06-30 $1.68B $1.03B 1.64
2018-03-31 $1.68B $1.07B 1.57
2017-12-31 $1.72B $1.15B 1.50
2017-09-30 $1.58B $1.08B 1.46
2017-06-30 $1.55B $1.01B 1.53
2017-03-31 $1.55B $1.31B 1.18
2016-12-31 $1.55B $1.40B 1.11
2016-09-30 $1.50B $1.34B 1.12
2016-06-30 $1.51B $1.00B 1.52
2016-03-31 $1.81B $0.98B 1.85
2015-12-31 $1.80B $0.96B 1.89
2015-09-30 $1.77B $1.00B 1.77
2015-06-30 $1.82B $1.02B 1.79
2015-03-31 $1.92B $1.03B 1.87
2014-12-31 $1.77B $0.93B 1.91
2014-09-30 $1.73B $0.88B 1.96
2014-06-30 $1.76B $0.88B 2.00
2014-03-31 $1.73B $0.90B 1.92
2013-12-31 $1.65B $0.91B 1.80
2013-09-30 $1.55B $0.88B 1.77
2013-06-30 $1.54B $1.00B 1.54
2013-03-31 $1.57B $0.98B 1.60
2012-12-31 $1.54B $0.92B 1.67
2012-09-30 $1.49B $0.90B 1.66
2012-06-30 $1.34B $0.85B 1.58
2012-03-31 $1.38B $0.85B 1.61
2011-12-31 $1.36B $0.97B 1.39
2011-09-30 $1.16B $1.05B 1.10
2011-06-30 $1.09B $0.92B 1.19
2011-03-31 $1.07B $0.92B 1.16
2010-12-31 $0.92B $0.74B 1.25
2010-09-30 $0.91B $0.71B 1.28
2010-06-30 $0.92B $0.65B 1.42
2010-03-31 $0.94B $0.65B 1.45
2009-12-31 $0.80B $0.47B 1.70
2009-09-30 $0.78B $0.50B 1.57
2009-06-30 $0.82B $0.53B 1.55
2009-03-31 $0.77B $0.52B 1.47
2008-12-31 $0.79B $0.58B 1.35
2008-09-30 $0.82B $0.62B 1.32
2008-06-30 $0.79B $0.54B 1.45
2008-03-31 $0.87B $0.49B 1.79
2007-12-31 $0.84B $0.44B 1.91
2007-09-30 $0.84B $0.43B 1.95
2007-06-30 $0.77B $0.37B 2.06
2007-03-31 $0.87B $0.43B 2.02
2006-12-31 $0.84B $0.54B 1.54
2006-09-30 $0.64B $0.59B 1.09
2006-06-30 $0.56B $0.54B 1.04
2006-03-31 $0.45B $0.42B 1.07
2005-12-31 $0.43B $0.21B 2.03
2005-09-30 $0.48B $0.21B 2.31
2005-06-30 $0.46B $0.20B 2.28
2005-03-31 $0.42B $0.17B 2.42
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.939B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.676B 8.40
Teva Pharmaceutical Industries (TEVA) Israel $17.694B 6.11
Mylan (MYL) United Kingdom $16.304B 6.71
Bausch Health Cos (BHC) Canada $8.412B 5.98
Supernus Pharmaceuticals (SUPN) United States $1.968B 18.64
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.768B 2.95
Amphastar Pharmaceuticals (AMPH) United States $1.134B 123.05
Homology Medicines (FIXX) United States $0.930B 0.00
CymaBay Therapeutics (CBAY) United States $0.593B 0.00
Assembly Biosciences (ASMB) United States $0.541B 0.00
Akorn (AKRX) United States $0.507B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.402B 0.00
Voyager Therapeutics (VYGR) United States $0.355B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.307B 0.00
Sol-Gel Technologies (SLGL) Israel $0.122B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.086B 0.00
Teligent (TLGT) United States $0.077B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Evoke Pharma (EVOK) United States $0.054B 0.00
Agile Therapeutics (AGRX) United States $0.033B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.004B 0.00